NewMarket Corporation
NYSE:NEUChemicals - Specialty
+$0.38 today
- Market cap
- $6.47B
- Beta
- 0.58
- P/E (TTM)
- 17.5
- EPS (TTM)
- $43.72
- Dividend yield
- 1.54%
Volume 0.17M
Average 0.11M
NEU EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
NewMarket CorporationNYSE: NEU
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $210.96M rose 12.9% year over year, ahead of the -5.9% change in trailing-twelve-month EBITDA. Sequentially, it rose 9.8% from the prior quarter. Over 3 fiscal years it compounded at +15.8% a year.
Context
- EBITDA amounted to 26.5% of revenue in FY2025, down 0.7 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +12.9% holds above the trailing-twelve-month pace of -5.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 722.68M USD
- Year-over-year change
- -4.7%
- 4-year CAGR
- +18.5%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 722.68M | -4.7% |
| FY2024 | 2024-12-31 | 758.43M | +25.5% |
| FY2023 | 2023-12-31 | 604.33M | +29.9% |
| FY2022 | 2022-12-31 | 465.22M | +27.1% |
| FY2021 | 2021-12-31 | 366.09M | — |
EBITDA vs competitors
How NEU compares with its peers on the latest reported figures
- NEU's LTM Jun 2026 EBITDA of $735.21M is the 2nd highest of the 11 companies compared; the peer median is $321.72M.
- Its year-over-year change of -5.9% is the 6th highest of 11, against a peer median of -1.2%.
- EBITDA amounts to 26.8% of revenue for NEU, versus a peer median of 16.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.27B | -26.3% | -7.6% | 14.3% | |
| LTM Jun 2026 | $735.21M | -5.9% | +15.8% | 26.8% | |
| LTM Jun 2026 | $690M | -14.9% | +13.9% | 19.0% | |
| LTM Aug 2026 | $540.79M | +11.0% | +2.4% | 15.2% | |
| LTM Jun 2026 | $380M | +176.5% | — | 20.6% | |
| LTM Apr 2026 | $368.4M | +142.5% | -20.3% | 17.3% | |
| LTM Sep 2026 | $275.03M | +10.4% | +9.2% | 24.8% | |
| LTM Sep 2026 | $232.84M | +46.9% | +6.3% | 11.5% | |
| LTM Jun 2026 | $181M | -12.7% | -7.0% | 9.8% | |
| LTM Mar 2026 | $139.93M | -27.5% | -10.3% | 6.0% | |
| LTM Jun 2026 | -$300.15M | -303.2% | — | 39.6% | |
| Peer median (excluding NEU) | $321.72M | -1.2% | -2.3% | 16.3% | |
Competitors are the stored peer set for NEU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.36B | 2.76B | 2.7B | 2.79B | 2.73B |
| Cost of Revenue | 1.81B | 2.12B | 1.93B | 1.9B | 1.87B |
| Gross Profit | 547.71M | 640.5M | 772.51M | 886.35M | 857.4M |
| Gross Margin | 23.2% | 23.2% | 28.6% | 31.8% | 31.5% |
| Research & Development | 143.95M | 140.25M | 138M | 124.9M | 132.09M |
| Selling, General & Admin | 145.97M | 145.11M | 151.47M | 171.41M | 181.58M |
| Operating Expenses | 289.93M | 285.36M | 289.47M | 296.31M | 313.68M |
| Depreciation & Amortization | 84.32M | 82.29M | 78.01M | 116.96M | 122.42M |
| EBITDA | 366.09M | 465.22M | 604.33M | 758.43M | 722.68M |
| EBITDA Margin | 15.5% | 16.8% | 22.4% | 27.2% | 26.5% |
| Operating Income | 257.78M | 355.14M | 483.05M | 590.04M | 543.73M |
| Operating Margin | 10.9% | 12.8% | 17.9% | 21.2% | 20.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 34.22M | 35.2M | 37.36M | 57.37M | 39.69M |
| Other Income / Expenses | (10.23M) | (7.41M) | 5.92M | (5.93M) | 16.84M |
| Income Before Tax | 247.55M | 347.73M | 488.96M | 584.11M | 560.56M |
| Pre-Tax Margin | 10.5% | 12.6% | 18.1% | 21.0% | 20.6% |
| Income Tax Expense | 56.64M | 68.2M | 100.1M | 121.69M | 141.82M |
| Net Income | 190.91M | 279.54M | 388.86M | 462.41M | 418.75M |
| Net Margin | 8.1% | 10.1% | 14.4% | 16.6% | 15.4% |
| EPS (Basic) | 17.71 | 27.77 | 40.44 | 48.22 | 44.44 |
| EPS (Diluted) | 17.71 | 27.77 | 40.44 | 48.22 | 44.44 |
| Weighted Avg Shares | 10.76M | 10.04M | 9.58M | 9.56M | 9.39M |
| Weighted Avg Shares (Diluted) | 10.76M | 10.04M | 9.58M | 9.56M | 9.39M |
NewMarket Corporation
NYSE:NEU
Intrinsic Alpha fair value
Locked
Current Price
$703.23
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.